126 related articles for article (PubMed ID: 25483731)
1. Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines.
Wang F; Lin F; Zhang P; Ni W; Bi L; Wu J; Jiang L
Oncol Rep; 2015 Feb; 33(2):967-73. PubMed ID: 25483731
[TBL] [Abstract][Full Text] [Related]
2. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.
Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; Hsu CH; Kirkpatrick DL; Powis G
J Lab Clin Med; 2006 Feb; 147(2):83-90. PubMed ID: 16459166
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
[TBL] [Abstract][Full Text] [Related]
4. PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis.
You BR; Shin HR; Park WH
Int J Oncol; 2014 Jan; 44(1):301-8. PubMed ID: 24172913
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.
Jordan BF; Runquist M; Raghunand N; Gillies RJ; Tate WR; Powis G; Baker AF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):529-36. PubMed ID: 15701837
[TBL] [Abstract][Full Text] [Related]
6. Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo.
Lin QD; Liu LN; Liu XY; Yan Y; Fang BJ; Zhang YL; Zhou J; Li YF; Zuo WL; Song YP
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1283-1292. PubMed ID: 35253185
[TBL] [Abstract][Full Text] [Related]
7. PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner.
You BR; Shin HR; Han BR; Park WH
Tumour Biol; 2015 Mar; 36(3):2087-95. PubMed ID: 25391429
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
Kim YH; Coon A; Baker AF; Powis G
Cancer Chemother Pharmacol; 2011 Aug; 68(2):405-13. PubMed ID: 21069338
[TBL] [Abstract][Full Text] [Related]
9. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
Welsh SJ; Williams RR; Birmingham A; Newman DJ; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2003 Mar; 2(3):235-43. PubMed ID: 12657718
[TBL] [Abstract][Full Text] [Related]
10. The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression.
Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Ohtori S; Yonemoto T
Anticancer Res; 2021 Dec; 41(12):6013-6021. PubMed ID: 34848455
[TBL] [Abstract][Full Text] [Related]
11. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
12. A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.
Ramanathan RK; Kirkpatrick DL; Belani CP; Friedland D; Green SB; Chow HH; Cordova CA; Stratton SP; Sharlow ER; Baker A; Dragovich T
Clin Cancer Res; 2007 Apr; 13(7):2109-14. PubMed ID: 17404093
[TBL] [Abstract][Full Text] [Related]
13. Drug evaluation: the thioredoxin inhibitor PX-12 in the treatment of cancer.
Galmarini CM
Curr Opin Investig Drugs; 2006 Dec; 7(12):1108-15. PubMed ID: 17209529
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides.
Kirkpatrick DL; Kuperus M; Dowdeswell M; Potier N; Donald LJ; Kunkel M; Berggren M; Angulo M; Powis G
Biochem Pharmacol; 1998 Apr; 55(7):987-94. PubMed ID: 9605422
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells.
Haas B; Schütte L; Wos-Maganga M; Weickhardt S; Timmer M; Eckstein N
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248944
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells.
Tang T; Fang D; Ji Z; Zhong Z; Zhou B; Ye L; Jiang L; Sun X
Cell Oncol (Dordr); 2024 Apr; 47(2):607-621. PubMed ID: 37867183
[TBL] [Abstract][Full Text] [Related]
17. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells.
Lundberg M; Mattsson Å; Reiser K; Holmgren A; Curbo S
Sci Rep; 2019 Apr; 9(1):5656. PubMed ID: 30948772
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P.
Lin F; Zhang P; Zuo Z; Wang F; Bi R; Shang W; Wu A; Ye J; Li S; Sun X; Wu J; Jiang L
Cancer Lett; 2017 Aug; 401():1-10. PubMed ID: 28483515
[TBL] [Abstract][Full Text] [Related]
20. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
